Mylan Taking Immediate Action to Further Enhance Access to EpiPen® (Epinephrine Injection, USP) Auto-Injector

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. ACN
4. IBM
5. DPZ
6. PRIM
7. META
8. IMNN
9. NAVN
10. NVDA

Go back to Mylan Taking Immediate Action to Further Enhance Access to EpiPen® (Epinephrine Injection, USP) Auto-Injector

Elijah Cummings Says Mylan's (MYL) Meager Discount Merely 'PR Move'

August 25, 2016 10:42 AM EDT

Elijah Cummings Says Mylan's (Nasdaq: MYL) Meager Discount Merely 'PR Move'

... More

Mylan's (MYL) Steps on EpiPen Do Not Go Far Enough - Wells Fargo's Maris

August 25, 2016 10:33 AM EDT

Wells Fargo analyst David Maris weighed in on Mylan (NASDAQ: MYL) after the company announced it will expand its existing EpiPen access program with a $300 savings card and increased eligibility, amid mounting political pressure.

Maris said while a good start, these steps do not go far enough to address the underlying issues the Senate and many parents are concerned about, and as such, they believe an FTC investigation and Senate hearings are still a possibility.

The analyst said the steps... More

Mylan (MYL) Gains Early After Taking Action on EpiPen Pricing

August 25, 2016 7:51 AM EDT

After dropping sharply over the past few sessions on headline risk related to EpiPen pricing, Mylan (NASDAQ: MYL) shares are gaining 3% early after the company announced plans to reduce patient cost through savings card which will cover up to $300 for their EpiPen 2-Pak.

... More